Literature DB >> 2336300

Septic shock in children: bacterial etiologies and temporal relationships.

R F Jacobs1, M K Sowell, M M Moss, D H Fiser.   

Abstract

In a retrospective analysis of 2110 admissions to the pediatric intensive care unit, 564 cases of septic shock were identified (26.7% of the total admissions). Septic shock was defined in patients with: (1) clinical evidence of sepsis; (2) fever (greater than 38.3 degrees C) or hypothermia (less than 35.6 degrees C); (3) tachycardia; (4) tachypnea; and (5) inadequate organ perfusion. Inadequate perfusion was defined as hypotension or evidence of peripheral hypoperfusion (poor capillary refill or cyanosis with hypoxemia, oliguria, acidosis or altered mentation). Inotropic support was required to maintain an adequate blood pressure and perfusion in 268 of 564 patients (47.5%). Septic shock with confirmed bacterial infection occurred in 143 patients (143 of 564, 25.2%); these cases were caused by Haemophilus influenzae, type b (59 of 143, 41.3%), Neisseria meningitidis (26 of 143, 18.2%) and Streptococcus pneumoniae (16 of 143, 11.2%). Eight of 564 (1.4%) cases of septic shock were not clinically apparent on initial evaluation and were diagnosed within 24 hours after admission to the hospital. We conclude that septic shock occurs more frequently in children than previously appreciated and may develop after admission to the hospital.

Entities:  

Mesh:

Year:  1990        PMID: 2336300     DOI: 10.1097/00006454-199003000-00010

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

1.  Frequency of low-level bacteremia in children from birth to fifteen years of age.

Authors:  J A Kellogg; J P Manzella; D A Bankert
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Activation of the L-arginine nitric oxide pathway in severe sepsis.

Authors:  T Duke; M South; A Stewart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 3.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 4.  The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy.

Authors:  T Darville; B Giroir; R Jacobs
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

Review 5.  Management of sepsis and septic shock in infants and children.

Authors:  N von Rosenstiel; I von Rosenstiel; D Adam
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

6.  Incidence and risk factors for mortality in paediatric severe sepsis: results from the national paediatric intensive care registry in Japan.

Authors:  Nobuaki Shime; Tatsuya Kawasaki; Osamu Saito; Yoko Akamine; Yuichiro Toda; Muneyuki Takeuchi; Hiroko Sugimura; Yoshio Sakurai; Masatoshi Iijima; Ikuya Ueta; Naoki Shimizu; Satoshi Nakagawa
Journal:  Intensive Care Med       Date:  2012-04-18       Impact factor: 17.440

Review 7.  Septic shock: pathogenesis and treatment.

Authors:  L Castillo; M Sanchez
Journal:  Indian J Pediatr       Date:  1993 May-Jun       Impact factor: 1.967

8.  Incidence of and mortality due to sepsis, severe sepsis and septic shock in Italian Pediatric Intensive Care Units: a prospective national survey.

Authors:  Andrea Wolfler; Paolo Silvani; Massimo Musicco; Massimo Antonelli; Ida Salvo
Journal:  Intensive Care Med       Date:  2008-05-24       Impact factor: 17.440

9.  Serum lactate levels as the predictor of outcome in pediatric septic shock.

Authors:  Kana Ram Jat; Urmila Jhamb; Vinod K Gupta
Journal:  Indian J Crit Care Med       Date:  2011-04

10.  Comparison of broad range 16S rDNA PCR and conventional blood culture for diagnosis of sepsis in the newborn: a case control study.

Authors:  Tonje Reier-Nilsen; Teresa Farstad; Britt Nakstad; Vigdis Lauvrak; Martin Steinbakk
Journal:  BMC Pediatr       Date:  2009-01-19       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.